The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features

 

Andrea Aloia1, Evgeniya Petrova2,3, Stefan Tomiuk1, Ute Bissels1, Sophie Banis2, Olivier Deas2, Silvia Rüberg1, Bernhard Gerstmayer1, David Agorku1, Jean-Gabriel Judde2, Andreas Bosio1, Olaf Hardt1 and Stefano Cairo2.

1 Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; 2 Xentech, Evry, France; 3 Institut Pasteur, Paris, France.

Poster in collaboration with Miltenyi, AACR 2015

bt-news